South Korea
· Delayed Price · Currency is KRW MegaMD Statistics
Total Valuation
MegaMD has a market cap or net worth of KRW 44.92 billion. The enterprise value is 1.87 billion.
| Market Cap | 44.92B |
| Enterprise Value | 1.87B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MegaMD has 22.07 million shares outstanding.
| Shares Outstanding | 22.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 4.23% |
| Float | 10.55M |
Valuation Ratios
The trailing PE ratio is 35.39.
| PE Ratio | 35.39 |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| PB Ratio | 0.70 |
| P/FCF Ratio | 7.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.37, with an EV/FCF ratio of 0.29.
| EV / Earnings | 1.47 |
| EV / Sales | 0.05 |
| EV / EBITDA | 0.37 |
| EV / EBIT | n/a |
| EV / FCF | 0.29 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 5.73.
| Current Ratio | 2.33 |
| Quick Ratio | 2.28 |
| Debt / Equity | 5.73 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.58 |
| Interest Coverage | 2.49 |
Financial Efficiency
Return on equity (ROE) is 2.00% and return on invested capital (ROIC) is 0.62%.
| Return on Equity (ROE) | 2.00% |
| Return on Assets (ROA) | 0.49% |
| Return on Capital (ROIC) | 0.62% |
| Revenue Per Employee | 229.74M |
| Profits Per Employee | 8.14M |
| Employee Count | 156 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 28.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.20% |
| 50-Day Moving Average | 2,119.80 |
| 200-Day Moving Average | 2,515.93 |
| Relative Strength Index (RSI) | 44.26 |
| Average Volume (20 Days) | 1,706,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MegaMD had revenue of KRW 35.84 billion and earned 1.27 billion in profits. Earnings per share was 57.50.
| Revenue | 35.84B |
| Gross Profit | 21.07B |
| Operating Income | 681.09M |
| Pretax Income | 1.65B |
| Net Income | 1.27B |
| EBITDA | 5.89B |
| EBIT | 681.09M |
| Earnings Per Share (EPS) | 57.50 |
Balance Sheet
The company has 46.73 billion in cash and 3.67 billion in debt, giving a net cash position of 43.05 billion or 1,950.33 per share.
| Cash & Cash Equivalents | 46.73B |
| Total Debt | 3.67B |
| Net Cash | 43.05B |
| Net Cash Per Share | 1,950.33 |
| Equity (Book Value) | 64.10B |
| Book Value Per Share | 2,903.69 |
| Working Capital | 28.36B |
Cash Flow
In the last 12 months, operating cash flow was 6.81 billion and capital expenditures -443.21 million, giving a free cash flow of 6.37 billion.
| Operating Cash Flow | 6.81B |
| Capital Expenditures | -443.21M |
| Free Cash Flow | 6.37B |
| FCF Per Share | 288.47 |
Margins
Gross margin is 58.79%, with operating and profit margins of 1.90% and 3.54%.
| Gross Margin | 58.79% |
| Operating Margin | 1.90% |
| Pretax Margin | 4.61% |
| Profit Margin | 3.54% |
| EBITDA Margin | 16.42% |
| EBIT Margin | 1.90% |
| FCF Margin | 17.77% |
Dividends & Yields
MegaMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.83% |
| FCF Yield | 14.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |